Login
Zimmer Biomet Holdings, Inc logo

Zimmer Biomet Holdings, Inc

zimmerbiomet.com

Zimmer Biomet Holdings, Inc (NYSE: ZBH) is a medical device company that designs, manufactures, and sells reconstructive orthopedic implants and related surgical products. Revenue is generated through transactional sales of implants and instruments to hospitals and surgical facilities, with surgeons and healthcare systems as the primary customers. The company operates across knees, hips, shoulders, elbows, and other joints, and competes in the global orthopedic reconstruction market. The 10-K filed 2026-02-20 (accession 000119312526059853) identifies competition, pricing pressures, dependence on new product development, and shifts in product category and regional sales mix as material business risks, consistent with a transactional implant business where product cycles and hospital contracting drive revenue. The filing also flags customer demand changes driven by demographic shifts as a demand driver, pointing to aging populations as a key end-market tailwind. Zimmer Biomet is incorporated in the United States and headquartered in Warsaw, Indiana.

Products & Services

Reconstructive orthopedic implants for knees, hips, shoulders, elbows, and other joints; surgical instruments and related products. The filing references a product portfolio rationalization plan as of the FY2025 10-K (filed 2026-02-20).

Revenue Model

Transactional sales of orthopedic implants, instruments, and related products to hospitals and surgical facilities. Revenue varies by product category mix and regional geography, as noted in the FY2025 10-K (filed 2026-02-20).

Customers & Markets

Hospitals, surgical facilities, and surgeons. End market demand is tied to orthopedic reconstruction procedures, with demographic changes identified as a driver of customer demand in the FY2025 10-K (filed 2026-02-20).

Geographic Exposure

The FY2025 10-K (filed 2026-02-20) references regional sales mix as a factor affecting results, indicating multi-geographic operations, but specific country or segment revenue breakdowns are not supported by the provided excerpts.

Financial Snapshot

Revenue
TTM
$8.409B
Gross Margin
TTM
70.15%
Net Income
TTM
$760.7M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
173.25%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
12.68B
Cash
2026 Q1
P/E
TTM
24.15
Free Cash Flow
TTM
$1.167B

Stock Price

Loading...
Market Cap: $18.371 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support